Supreme Court Extends Access to Mifepristone Amid Ongoing Legal Battles

Want the full story?
Read the complete article at KVIA
AI Summary
The U.S. Supreme Court has temporarily extended access to the abortion pill mifepristone via telehealth consultations until Thursday at 5 p.m. ET. This decision comes as the court reviews an emergency appeal related to a recent ruling from the 5th Circuit Court of Appeals, which mandated in-person visits for obtaining the drug. The case is significant as it follows the overturning of Roe v. Wade, impacting access to abortion nationwide. Medical providers reported chaotic conditions following the initial ruling, prompting pharmaceutical companies to seek urgent intervention from the Supreme Court to maintain access for patients.
Key Details: • Access to mifepristone via telehealth is extended until Thursday at 5 p.m. ET. • The Supreme Court's decision follows a chaotic weekend for patients after the 5th Circuit ruling. • Danco Laboratories and GenBioPro filed emergency appeals to the Supreme Court to maintain access.